AUROLIFE PHARMA LLC FDA Approval ANDA 072395

ANDA 072395

AUROLIFE PHARMA LLC

FDA Drug Application

Application #072395

Application Sponsors

ANDA 072395AUROLIFE PHARMA LLC

Marketing Status

Discontinued001

Application Products

001CAPSULE;ORALEQ 300MG BASE0FENOPROFEN CALCIUMFENOPROFEN CALCIUM

FDA Submissions

ORIG1AP1988-10-14
LABELING; LabelingSUPPL2AP1989-03-31
BIOEQUIV; BioequivalenceSUPPL4AP1989-02-27
LABELING; LabelingSUPPL6AP1991-07-30
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1995-04-18

Submissions Property Types

SUPPL1Null0
SUPPL4Null0
SUPPL5Null0
SUPPL7Null0

CDER Filings

AUROLIFE PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 72395
            [companyName] => AUROLIFE PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"FENOPROFEN CALCIUM","activeIngredients":"FENOPROFEN CALCIUM","strength":"EQ 300MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"FENOPROFEN CALCIUM","submission":"FENOPROFEN CALCIUM","actionType":"EQ 300MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.